MAP3K7 and hepatocellular carcinoma: Given that the known role of TAK1 in promoting cell survival (anti-apoptotic activity) when cells were exposed to various stresses and inflammatory cytokines [59], [69], we tested if the removal of the 14-3-3ε binding affects the activation status of TAK1 and its concurrent anti-apoptotic activity in HCC cells.